Lentiviral vector delivery of short hairpin RNA to NG2 and neurotrophin-3 promotes locomotor recovery in injured rat spinal cord

Cytotherapy

Volumn 14, Issue 10, 2012, Pages 1235-1244

  Donnelly, Eleanor M ^a   Madigan, Nicolas N ^a,b   Rooney, Gemma E ^b   Knight, Andrew ^b   Chen, Bingkun ^b   Ball, Bret ^b   Kinnavane, Lisa ^a   Garcia, Yolanda ^a   Dockery, Peter ^a   Fraher, John ^c   Strappe, Padraig M ^d   Windebank, Anthony J ^b   O'Brien, Timothy ^a   McMahon, Siobhan S ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b MAYO CLINIC   (United States)

^c UNIVERSITY COLLEGE CORK   (Ireland)

^d CHARLES STURT UNIVERSITY   (Australia)

Author keywords

astrocytes; axon regeneration; chondroitin sulfate proteoglycans; glial scar; microglia; neurotrophin 3; NG2; spinal cord injury

Indexed keywords

LENTIVIRUS VECTOR; NEUROTROPHIN 3; NG2 PROTEIN; PROTEOCHONDROITIN SULFATE; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL LEVEL; CONTROLLED STUDY; CONTUSION; CONVALESCENCE; FEMALE; FUNCTIONAL ASSESSMENT; GENE TARGETING; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MACROPHAGE; MICROGLIA; MOLECULAR CLONING; MOLECULARLY TARGETED THERAPY; MOTOR PERFORMANCE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; SPINAL CORD INJURY; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

EID: 84867659030     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2012.714865     Document Type: Article

References (44)

1. Dietz V, Curt A. Neurological aspects of spinal cord repair: Promises and challenges. Lancet Neurol. 2006; 5: 688-94.
2. Houle J D, Tessler A. Repair of chronic spinal cord injury. Exp Neurol. 2003; 182: 247-60.
3. Hulsebosch CE. Recent advances in pathophysiology and treatment of spinal cord injury. Adv Physiol Edu. 2002; 26: 238-55.
4. Zai L J, Yoo S, Wrathall J R. Increased growth factor expression and cell proliferation after contusive spinal cord injury. Brain Res. 2005; 1052: 147-55.
5. Rudge JS, Silver J. Inhibition of neurite outgrowth on astroglial scars in vitro. J Neurosci. 1990; 10: 3594-603.
6. Faulkner JR, Herrmann JE, Woo MJ, Tansey KE, Doan NB, Sofroniew MV. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci. 2004; 24: 2143-55.
7. McKeon RJ, Schreiber RC, Rudge JS, Silver J. Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes. J Neurosci. 1991; 11: 3398-411.
8. Bradbury EJ, McMahon SB, Ramer MS. Keeping in touch: Sensory neurone regeneration in the CNS. Trends Pharmacol Sci. 2000; 21: 389-94.
9. Bradbury E J, Moon L D, Popat R J, King V R, Bennett G S, Patel PN, et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature. 2002; 416: 636-40.
10. Bu J, Akhtar N, Nishiyama A. Transient expression of the NG2 proteoglycan by a subpopulation of activated macrophages in an excitotoxic hippocampal lesion. Glia. 2001; 34: 296-310.
11. Ughrin YM, Chen ZJ, Levine JM. Multiple regions of the NG2 proteoglycan inhibit neurite growth and induce growth cone collapse. J Neurosci. 2003; 23: 175-86.
12. Colletti M, Rorai A T, Skene JH, Levine JM. Antibodies against the NG2 proteoglycan promote the regeneration of sensory axons within the dorsal columns of the spinal cord. J Neurosci. 2006; 26: 4729-39.
13. Jones LL, Margolis RU, Tuszynski MH. The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan and versican are differentially regulated following spinal cord injury. Exp Neurol. 2003; 182: 399-411.
14. Jones L L, Sajed D, Tuszynski M H. Axonal regeneration through regions of chondroitin sulfate proteoglycan deposition after spinal cord injury: A balance of permissiveness and inhibition. J Neurosci. 2003; 23: 9276-88.
15. Hossain-Ibrahim MK, Rezajooi K, Stallcup WB, Lieberman AR, Anderson PN. Analysis of axonal regeneration in the central and peripheral nervous systems of the NG2-deficient mouse. BMC Neurosci. 2007; 8:1-22.
16. McTigue DM, Tripathi R, Wei P. NG2 colocalizes with axons and is expressed by a mixed cell population in spinal cord lesions. JNeuropath Exp Neurol. 2006; 65: 406-20.
17. Harper SQ, Staber PD, He X, Eliason SL, Martins IH, Mao Q, et al. RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model. Proc Natl Acad Sci USA. 2005; 102: 5820-5.
18. Singer O, Marr R A, Rockenstein E. Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model. Nature Neurosci. 2005; 8: 1343-9.
19. Donnelly EM, Strappe PM, McGinley LM, Madigan NN, Geurts E, Rooney GE, et al. Lentiviral vector-mediated knockdown of the neuroglycan 2 proteoglycan or expression of neurotrophin-3 promotes neurite outgrowth in a cell culture model of the glial scar. JGene Med. 2010; 12: 863-72.
20. Tessarollo L, Tsoulfas P, Martin-Zanca D, Gilbert DJ, Jenkins NA, Copeland NG, Parada LF. trkC, a receptor for neurotrophin-3, is widely expressed in the developing nervous system and in non-neuronal tissues. Development. 1993; 118: 463-75.
21. Williams R, Backstrom A, Kullander K, Hallbook F, Ebendal T. Developmentally regulated expression of mRNA for neurotrophin high-affinity (trk) receptors within chick trigeminal sensory neurons. Eur J Neurosci. 1995; 7: 116-28.
22. Hari A, Djohar B, Skutella T, Montazeri S. Neurotrophins and extracellular matrix molecules modulate sensory axon outgrowth. Int J Develop Neurosci. 2004; 22: 113-7.
23. Alto L T, Havton L A, Conner J M, Hollis I ER, Blesch A, Tuszynski MH. Chemotropic guidance facilitates axonal regeneration and synapse formation after spinal cord injury. Nature Neurosci. 2009; 12: 1106-13.
24. Grill R, Murai K, Blesch A, Gage FH, Tuszynski MH. Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury. J Neurosci. 1997; 17: 5560-72.
25. Hory-Lee F, Russell M, Lindsay RM, Frank E. Neurotrophin 3 supports the survival of developing muscle sensory neurons in culture. Proc Natl Acad Sci USA. 1993; 90: 2613-7.
26. Massey JM, Amps J, Viapiano MS, Matthews RT, Wagoner MR, Whitaker CM, et al. Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3. Exp Neurol. 2008; 209: 426-45.
27. Ramer MS, Bishop T, Dockery P, Mobarak MS, O'Leary D, Fraher JP, et al. Neurotrophin-3-mediated regeneration and recovery of proprioception following dorsal rhizotomy. Mol Cell Neurosci. 2002; 19: 239-49.
28. Zhou L, Baumgartner B J, Hill-Felberg S J, McGowen L R, Shine HD. Neurotrophin-3 expressed in situ induces axonal plasticity in the adult injured spinal cord. J Neurosci. 2003; 23: 1424-31.
29. Blits B, Dijkhuizen P A, Boer G J, Verhaagen J. Intercostal nerve implants transduced with an adenoviral vector encoding neurotrophin-3 promote regrowth of injured rat corticospinal tract fibers and improve hindlimb function. Exp Neurol. 2000; 164: 25-37.
30. Bradbury E J, Khemani S, King V R, Priestley J V, McMahon SB. NT-3 promotes growth of lesioned adult rat sensory axons ascending in the dorsal columns of the spinal cord. Eur J Neurosci. 1999; 11: 3873-83.
31. Galtrey C M, Asher R A, Nothias F, Fawcett J W. Promoting plasticity in the spinal cord with chondroitinase improves functional recovery after peripheral nerve repair. Brain. 2007; 130: 926-39.
32. Ikegami T, Nakamura M, Yamane J, Katoh H, Okada S, Iwanami A, et al. Chondroitinase ABC combined with neural stem/progenitor cell transplantation enhances graft cell migration and outgrowth of growth-associated protein-43- positive fibers after rat spinal cord injury. Eur J Neurosci. 2005; 22: 3036-46.
33. Schnell L, Schneider R, Kolbeck R, Barde Y-A, Schwab ME. Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion. Nature. 1994; 367: 170-3.
34. de Castro R Jr, Tajrishi R, Claros J, Stallcup W B. Differential responses of spinal axons to transection: Infl uence of the NG2 proteoglycan. Exp Neurol. 2005; 192: 299-309.
35. Jones L L, Sajed D, Tuszynski M H. Axonal regeneration through regions of chondroitin sulfate proteoglycan deposition after spinal cord injury: A balance of permissiveness and inhibition. J Neurosci. 2003; 23: 9276-88.
36. Silver J, Miller J H. Regeneration beyond the glial scar. Nature Rev Neurosci. 2004; 5: 146-56.
37. Rolls A, Shechter R, Schwartz M. The bright side of the glial scar in CNS repair. Nature Rev Neurosci. 2009; 10: 235-41.
38. Giulian D, Woodward J, Young D, Krebs J, Lachman L. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J Neurosci. 1988; 8: 2485-90.
39. Nishino A, Suzuki M, Ohtani H, Motohashi O, Umezawa K, Nagura H, Yoshimoto T. Thrombin may contribute to the pathophysiology of central nervous system injury. J Neurotrauma. 1993; 10: 167-79.
40. Winter CG, Saotome Y, Levison SW, Hirsh D. Arole for ciliary neurotrophic factor as an inducer of reactive gliosis, the glial response to central nervous system injury. Proc Natl Acad Sci USA. 1995; 92: 5865-9.
41. Elkabes S, DiCicco-Bloom E, Black I. Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function. J Neurosci. 1996; 16: 2508-21.
42. Rabchevsky AG, Streit W J. Role of microglia in postinjury repair and regeneration of the CNS. Mental Retard Develop Disabilities Res Rev. 1998; 4: 187-92.
43. Fitch MT, Doller C, Combs CK, Landreth GE, Silver J. Cellular and molecular mechanisms of glial scarring and progressive cavitation: In vivo and in vitro analysis of infl ammation-induced secondary injury after CNS trauma. J Neurosci. 1999; 19: 8182-98.
44. Fitch MT, Silver J. Activated macrophages and the blood- brain barrier: Infl ammation after CNS injury leads to increases in putative inhibitory molecules. Exp Neurol. 1997; 148: 587-603.